ID   MyLa 1928
AC   CVCL_M416
SY   MyLa1928; MF1928
DR   Wikidata; Q54907180
RX   PubMed=16932349;
RX   PubMed=17179233;
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: T-cell; CL=CL_0000084.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8327 ! MyLa 1885
OI   CVCL_8328 ! MyLa 2000
OI   CVCL_8326 ! MyLa 3675
SX   Sex unspecified
AG   Age unspecified
CA   Finite cell line
DT   Created: 05-11-13; Last updated: 29-06-23; Version: 6
//
RX   PubMed=16932349; DOI=10.1038/sj.leu.2404350;
RA   Krejsgaard T.F., Vetter-Kauczok C.S., Woetmann A., Lovato P., Labuda T.,
RA   Eriksen K.W., Zhang Q., Becker J.C., Odum N.;
RT   "Jak3- and JNK-dependent vascular endothelial growth factor expression
RT   in cutaneous T-cell lymphoma.";
RL   Leukemia 20:1759-1766(2006).
//
RX   PubMed=17179233; DOI=10.1182/blood-2006-04-017863; PMCID=PMC1852254;
RA   Woetmann A., Lovato P., Eriksen K.W., Krejsgaard T.F., Labuda T.,
RA   Zhang Q., Mathiesen A.-M., Geisler C., Svejgaard A., Wasik M.A.,
RA   Odum N.;
RT   "Nonmalignant T cells stimulate growth of T-cell lymphoma cells in the
RT   presence of bacterial toxins.";
RL   Blood 109:3325-3332(2007).
//